A Bundled Intervention

Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Sep 9, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new approach to help people who have struggled with opioid use disorder and have experienced an opioid overdose. The goal is to reduce the risk of future overdoses and save lives, especially for those who have recently been treated in the emergency department (ED). The trial will offer a combination of support, including remote healthcare check-ins (telehealth), help from trained peer support specialists, medication called buprenorphine to manage cravings, and connections to ongoing care to ensure comprehensive treatment.

To participate in this trial, you must be at least 19 years old, have a diagnosis of opioid use disorder, and have had an overdose in the past year. You'll also need to be willing to continue taking buprenorphine after your ED visit. If you join, you can expect to receive personalized support and resources to help you on your recovery journey. It's important to note that certain individuals, such as those in jail or with severe health issues, won't be eligible for this study. This trial is currently recruiting participants, and everyone is welcome, regardless of gender.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. discharged from the ED and inpatient settings at the UAB hospital
• • 2. 19 years or older (the age of majority in Alabama);
• • 3. diagnosis of OUD and experiencing opioid overdose in the last 12 months;
• • 4. prescribed buprenorphine in the ED and willing to continue buprenorphine post-ED discharge;
• • 5. English speaking;
• • 6. not actively psychotic and suicidal, or cognitively impaired.
• • 7. Patients who are admitted to the hospital from the ED will be eligible for enrollment.
• Exclusion Criteria:
• • 1. living in a restricted environment (e.g., prison or jail facility, etc.);
• • 2. currently enrolled in other clinical studies;
• • 3. anticipated to take other prescribed opioids except buprenorphine for a medical condition longer than three months;
• • 4. known allergic reaction to buprenorphine;
• • 5. critically ill or injured;
• • 6. females with pregnancy (they are anticipated to request a higher level of care).
• • 7. living outside of Alabama